888-776-0942 from 8 AM - 10 PM ET
DUBLIN , June 24, 2022 /PRNewswire/ -- The "Global Therapeutics Contact Lens Market, By Material Type (Balafilcon, Lotrafilcon, Methafilcon, Senofilcon, Others), By Application (Pain Relief, Corneal Healing, Sealing & Protection, Others), By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Therapeutics Contact Lens Market is expected to grow at a steady CAGR of 12.10% to reach USD5788.23 million by 2027 on the back of the rise in the number of eye treatment surgeries happening across the globe. Also, the increased prevalence of myopia and other eye disorders and the growing use of advanced technologies for eye treatment are other prominent factors driving the Global Therapeutics Contact Lens Market. Contact lenses are safer and can provide effective vision correction compared to traditional eyewear. The government of several countries is investing heavily to develop the healthcare sector and emphasize the importance of vision care. They are launching awareness camps and campaigns to increase the awareness in the people about advanced eye care. Also, an increase in the number of myopia and other eye disorders is expected to create significant opportunities for the Global Therapeutics Contact Lens Market in the forecast period. The Global Therapeutics Contact Lens Market is segmented into material type, application, distribution channel, regional distribution, and competitive landscape. Based on material type, the market is divided into balafilcon, lotrafilcon, methafilcon, senofilcon, and others. The senofilcon material dominated the market in 2021 and accounted for 43.15% of the overall market share. This segment is expected to maintain its dominance throughout the forecast period. Senofilcon keeps the eye white and healthy and provides more relief for ocular discomfort. Some of the key players operating in the Global Therapeutics Contact Lens Market are Johnson & Johnson, Alcon, Inc, Bausch Health Companies, Inc, EssilorLuxottica S.A., Carl Zeiss Meditec AG, SynergEyes Inc., X-Cel Specialty Contacts., CooperVision, Inc., Hoya Corporation., SEED Co., Ltd, among others. Years considered for this report:
Key Topics Covered: 1. Product Overview 2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Therapeutics Contact Lens Market 5. Voice of Customer 5.1. References for Using Therapeutic Contact Lens Across Gender 5.2. Reasons for Using Therapeutic Contact Lens 5.3. Frequency of Therapeutic Contact Lens Usage 5.4. Preferred Point of Purchase 5.5. Factors Influencing Purchase Decision 5.6. Sources of Information 5.7. Barriers to Adoption of Therapeutic Contact Lens 5.8. Brand Awareness 6. Clinical Trials Analysis 6.1. Ongoing Clinical Trials 6.2. Completed Clinical Trials 6.3. Terminated Clinical Trials 7. Patent Analysis 7.1. Patent Granted (2017-2021) 7.2. Patent Applications Filed 8. Global Therapeutics Contact Lens Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Material Type (Senofilcon, Balafilcon, Lotrafilcon, Methafilcon, Others) 8.2.2. By Application (Drug Delivery, Corneal Healing, Pain Relief, Sealing & Protection, Drug Delivery, Others)) 8.2.3. By Distribution Channel (Hospitals & Clinics, Online, Optical Retail Stores) 8.2.4. By Company (2021) 8.2.5. By Region 8.3. Market Map 9. North America Therapeutics Contact Lens Market Outlook 10. Europe Therapeutics Contact Lens Market Outlook 11. Asia Pacific Therapeutics Contact Lens Market Outlook 12. South America Therapeutics Contact Lens Market Outlook 13. Middle East and Africa Therapeutics Contact Lens Market Outlook 14. Market Dynamics 14.1. Drivers 14.2. Challenges 15. Market Trends and Developments 16. Competitive Landscape 16.1. Johnson & Johnson 16.2. Alcon, Inc 16.3. Bausch Health Companies, Inc. 16.4. EssilorLuxottica S.A 16.5. Carl Zeiss Meditec AG 16.6. SynergEyes Inc. 16.7. X-Cel Specialty Contacts 16.8. CooperVision, Inc. 16.9. Hoya Corporation 16.10. SEED Co., Ltd. 17. Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/p3f7x4
Research and Markets Laura Wood , Senior Manager [email protected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
Cision Distribution 888-776-0942 from 8 AM - 9 PM ET